Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Magarian Blander

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|December 17, 2008
Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptorsJ Magarian Blander
Nature Reviews. Immunology|August 23, 2014
A long-awaited merger of the pathways mediating host defence and programmed cell deathJ Magarian Blander
Immunological Reviews|June 21, 2016
The comings and goings of MHC class I molecules herald a new dawn in cross-presentationJ Magarian Blander
Immunity|February 21, 2020
MerTK Blockade Fuels Anti-tumor ImmunityJ Magarian Blander
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2009
Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammationJ Magarian Blander
Current Opinion in Pharmacology|June 12, 2018
Exploiting vita-PAMPs in vaccinesJ Magarian Blander, Gaetan Barbet
Science (New York, N.Y.)|June 6, 2009
Immunology. Amino acid addictionJ Magarian Blander, Derk Amsen
Oncoimmunology|November 20, 2012
"Flagellated" cancer cells propel anti-tumor immunityJohan Garaude, J Magarian Blander
Science (New York, N.Y.)|November 10, 2018
A key ingredient for priming killer T cellsGaëtan Barbet, J Magarian Blander
Nature Immunology|March 15, 2024
Pas de deux of NLRP3 and ASC with CD63 on mast cell granulesJ Magarian Blander, Yuhua Shi
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|December 17, 2008
Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptorsJ Magarian Blander
Nature Reviews. Immunology|August 23, 2014
A long-awaited merger of the pathways mediating host defence and programmed cell deathJ Magarian Blander
Immunological Reviews|June 21, 2016
The comings and goings of MHC class I molecules herald a new dawn in cross-presentationJ Magarian Blander
Immunity|February 21, 2020
MerTK Blockade Fuels Anti-tumor ImmunityJ Magarian Blander
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2009
Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammationJ Magarian Blander
Current Opinion in Pharmacology|June 12, 2018
Exploiting vita-PAMPs in vaccinesJ Magarian Blander, Gaetan Barbet
Science (New York, N.Y.)|June 6, 2009
Immunology. Amino acid addictionJ Magarian Blander, Derk Amsen
Oncoimmunology|November 20, 2012
"Flagellated" cancer cells propel anti-tumor immunityJohan Garaude, J Magarian Blander
Science (New York, N.Y.)|November 10, 2018
A key ingredient for priming killer T cellsGaëtan Barbet, J Magarian Blander
Nature Immunology|March 15, 2024
Pas de deux of NLRP3 and ASC with CD63 on mast cell granulesJ Magarian Blander, Yuhua Shi
Pageof 9